These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 12385578)
1. The promoter polymorphism of the matrix metalloproteinase 3 (MMP-3) gene in women with ovarian cancer. Szyllo K; Smolarz B; Romanowicz-Makowska H; Niewiadomski M; Kozlowska E; Kulig A J Exp Clin Cancer Res; 2002 Sep; 21(3):357-61. PubMed ID: 12385578 [TBL] [Abstract][Full Text] [Related]
2. PCR analysis of matrix metalloproteinase 3 (MMP-3) gene promoter polymorphism in ovarian cancer. Smolarz B; Szyłło K; Romanowicz-Makowska H; Niewiadomski M; Kozłowska E; Kulig A Pol J Pathol; 2003; 54(4):233-8. PubMed ID: 14998290 [TBL] [Abstract][Full Text] [Related]
3. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer]. Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531 [TBL] [Abstract][Full Text] [Related]
4. [Association of single nucleotide polymorphism in matrix metalloproteinases promoter with susceptibility to ovarian cancer]. Li Y; Wang Y; Kang S; Zhang JH; Guo W; Wang N; Jin X; Fang SM Zhonghua Fu Chan Ke Za Zhi; 2005 Jul; 40(7):472-5. PubMed ID: 16080875 [TBL] [Abstract][Full Text] [Related]
5. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Ghilardi G; Biondi ML; Caputo M; Leviti S; DeMonti M; Guagnellini E; Scorza R Clin Cancer Res; 2002 Dec; 8(12):3820-3. PubMed ID: 12473595 [TBL] [Abstract][Full Text] [Related]
6. The functional SNP in the matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic metastasis in esophageal squamous cell carcinoma but not in gastric cardiac adenocarcinoma. Zhang J; Jin X; Fang S; Li Y; Wang R; Guo W; Wang N; Wang Y; Wen D; Wei L; Kuang G; Dong Z Carcinogenesis; 2004 Dec; 25(12):2519-24. PubMed ID: 15319302 [TBL] [Abstract][Full Text] [Related]
7. [Correlations of polymorphisms in matrix metalloproteinase-3 and -7 promoters to susceptibility to brain astrocytoma]. Lu ZQ; Wang YM; Cao YY; Zhang QJ; Zhang XH; Li YH; Wang HS; Xie HL; Jiao BH; Zhang JH Ai Zheng; 2007 May; 26(5):463-8. PubMed ID: 17672933 [TBL] [Abstract][Full Text] [Related]
8. [Single nucleotide polymorphism in the matrix metalloproteinases promoter is associated with susceptibility to endometriosis and adenomyosis]. Kang S; Wang Y; Zhang JH; Jin X; Fang SM; Li Y Zhonghua Fu Chan Ke Za Zhi; 2005 Sep; 40(9):601-4. PubMed ID: 16202315 [TBL] [Abstract][Full Text] [Related]
9. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer. Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710 [TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China. Li Y; Jin X; Kang S; Wang Y; Du H; Zhang J; Guo W; Wang N; Fang S Gynecol Oncol; 2006 Apr; 101(1):92-6. PubMed ID: 16278009 [TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in the MMP-1 and MMP-3 gene may contribute to chronic periodontitis in a Brazilian population. Astolfi CM; Shinohara AL; da Silva RA; Santos MC; Line SR; de Souza AP J Clin Periodontol; 2006 Oct; 33(10):699-703. PubMed ID: 16899023 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Zinzindohoué F; Lecomte T; Ferraz JM; Houllier AM; Cugnenc PH; Berger A; Blons H; Laurent-Puig P Clin Cancer Res; 2005 Jan; 11(2 Pt 1):594-9. PubMed ID: 15701845 [TBL] [Abstract][Full Text] [Related]
13. Association of -1171 promoter polymorphism of matrix metalloproteinase-3 with increased risk for oral cancer. Vairaktaris E; Yapijakis C; Vasiliou S; Derka S; Nkenke E; Serefoglou Z; Vorris E; Vylliotis A; Ragos V; Neukam FW; Patsouris E Anticancer Res; 2007; 27(6B):4095-100. PubMed ID: 18225577 [TBL] [Abstract][Full Text] [Related]
14. Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Kanamori Y; Matsushima M; Minaguchi T; Kobayashi K; Sagae S; Kudo R; Terakawa N; Nakamura Y Cancer Res; 1999 Sep; 59(17):4225-7. PubMed ID: 10485461 [TBL] [Abstract][Full Text] [Related]
15. Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma. Hirata H; Okayama N; Naito K; Inoue R; Yoshihiro S; Matsuyama H; Suehiro Y; Hamanaka Y; Hinoda Y Carcinogenesis; 2004 Dec; 25(12):2379-84. PubMed ID: 15319295 [TBL] [Abstract][Full Text] [Related]
16. [Association between serum matrix metalloproteinase-3 concentration and the promoter 5A/6A polymorphism in patients with coronary heart disease]. Gao B; Li ZC Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Sep; 16(9):536-9. PubMed ID: 15355616 [TBL] [Abstract][Full Text] [Related]
17. Association of the matrix metalloproteinase-3 (MMP-3) promoter polymorphism with celiac disease in male subjects. Mora B; Bonamico M; Ferri M; Megiorni F; Osborn J; Pizzuti A; Mazzilli MC Hum Immunol; 2005 Jun; 66(6):716-20. PubMed ID: 15993717 [TBL] [Abstract][Full Text] [Related]
18. Association of functional gene polymorphisms of matrix metalloproteinase (MMP)-1, MMP-3 and MMP-9 with the progression of chronic liver disease. Okamoto K; Mimura K; Murawaki Y; Yuasa I J Gastroenterol Hepatol; 2005 Jul; 20(7):1102-8. PubMed ID: 15955221 [TBL] [Abstract][Full Text] [Related]
19. Influence of genetic polymorphism in matrix metalloproteinase-3 on extent of coronary atherosclerosis and risk of coronary artery stenosis. Seifi M; Fallah S; Firoozrai M Arch Med Res; 2009 Oct; 40(7):600-4. PubMed ID: 20082876 [TBL] [Abstract][Full Text] [Related]